Mutants of Escherichia coli heat-labile enterotoxin as an adjuvant for nasal influenza vaccine

Vaccine

Volumn 16, Issue 2-3, 1998, Pages 248-254

  Komase, Katsuhiro ^a   Tamura, Shin Ichi ^b   Matsuo, Kazutoshi ^b   Watanabe, Kouji ^a   Hattori, Nobuaki ^a   Odaka, Ayako ^a   Suzuki, Yujiro ^a   Kurata, Takeshi ^b   Aizawa, Chikara ^a  

^a KITASATO INSTITUTE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Adjuvant; Mucosal immunity; Mutant E. coli heat labile enterotoxins; Nasal influenza vaccine

Indexed keywords

ADJUVANT; ENTEROTOXIN; INFLUENZA VACCINE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIUM MUTANT; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; IMMUNIZATION; IN VITRO STUDY; INFLUENZA; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; BACTERIAL TOXINS; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; MUTATION;

EID: 0031986227     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00176-X     Document Type: Article

References (35)

1. 1 Murphy, B.R. and Webster, R.G., Orthomyxoviruses. In Virology, 2nd edn., ed. B.N. Fields, D.M. Knipe et al., Raven Press, New York, 1990, pp. 1091-1152.
2. 2 Wilson, I.R. and Cox, J.C. Structural basis of immune recognition of influenza virus hemagglutinin. Annual Review of Immunology 1990, 8, 737-771.
3. 3 Mayer, H.M. Jr., Hopps, H.E., Parleman, P.D. and Ennis, F.A. Review of existing vaccines for influenza. American Journal of Clinical Pathology 1978, 70, 146-152.
4. 4 Schulman, J.L. and Kilbourne, E.D. Induction of partial specific heterotypic immunity in mice by a single infection with influenza A virus. Journal of Bacteriology 1965, 89, 170-174.
5. 5 Hoskins, T.W., Davies, J.R., Smith, A.J., Allchin, A., Miller, C.L. and Pollock, T.M. Influenza at Christ's Hospital. Lancet, 1974, i, 105-106.
6. 6 Couch, R.B. and Kasel, J.A. Immunity to influenza in man. Annual Review of Microbiology 1983, 37, 529-549.
7. 7 Liew, F.Y., Russell, S.M., Appleyard, G., Brand, C.M. and Beale, J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell activity. European Journal of Immunology 1984, 14, 350-356.
8. 8 Waldman, R.H. and Ganguly, R. Immunity to infection on secretory surfaces. Journal of Infectious Diseases 1974, 130, 419-440.
9. 9 Tamura, S.-I., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. and Kurata, T. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 1988, 6, 409-413.
10. 10 Tamura, S.-I., Ito, Y., Asanuma, H., Hirabayashi, Y., Suzuki, Y., Nagamine, T., Aizawa, C. and Kurata, T. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. Journal of Immunology 1992, 149, 981-988.
11. 11 Tamura, S.-I., Yamanaka, A., Shimohara, M., Tomita, T., Komase, K., Tsuda, Y., Suzuki, Y., Nagamine, T., Kawahara, K., Danbara, H., Aizawa, C., Oya, A. and Kurata, A. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 419-426.
12. 12 Tamura, S.-I., Asanuma, H., Tomita, T., Komase, K., Kawahara, K., Danbara, H., Hattori, N., Watanabe, K., Suzuki, Y., Nagamine, T., Aizawa, C., Oya, A. and Kurata, T. Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 1083-1089.
13. 13 Hashiguchi, K., Ogawa, H., Ishidate, T., Yamashita, R., Kamiya, H., Watanabe, K., Hattori, N., Sato, T., Suzuki, Y., Nagamine, T., Aizawa, C., Tamura, S.-I., Kurata, T. and Oya, A. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin. Vaccine 1996, 14, 113-119.
14. 14 Dallas, W.S. and Falkow, S. Amino acid homology between cholera toxin and Escherichia coli heat-labile toxin. Nature 1980, 288, 499-501.
15. 15 Spangler, B.D. Structure and function of cholera toxin and related Escherichia coli enterotoxin. Microbiology Reviews 1992, 56, 622-647.
16. 16 Elson, C.O. and Ealding, W. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. Journal of Immunology 1984, 133, 2892-2897.
17. 17 Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 1986, 59, 301-308.
18. 18 Clements, J.D., Hartzog, N.M. and Lyon, F.L. Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens. Vaccine 1988, 6, 269-277.
19. 19 Walker, R.I. and Clements, J.D. Use of heat-labile toxin of enterotoxigenic Escherichia coli to facilitate mucosal immunization. Vaccine Research 1993, 2, 1-10.
20. 20 Douce, G., Turcotte, C., Cropley, I., Roberts, M., Pizza, M., Domenghini, M., Rappuoli, R. and Dougan, G. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvant. Proceedings of the National Academy of Sciences of the United States of America 1995, 92, 1644-1648.
21. 21 Dickinson, B.L. and Clements, J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infection and Immunity 1995, 63, 1617-1623.
22. 22 Lobet, Y., Cluff, C.W. and Cieplak, W. Jr. Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin. Infection and Immunity 1991, 59, 2870-2879.
23. 23 Harford, S., Dykes, C.W., Hobden, A.N., Read, M.J. and Halliday, I.J. Inactivation of the Escherichia coli heat-labile enterotoxin by in vitro mutagenesis of the A-subunit gene. European Journal of Biochemistry 1989, 183, 311-316.
24. 24 Tsuji, T., Inoue, T., Miyama, A., Okamoto, K., Honda, T. and Miwatani, T. A single amino acid substitution in the A subunit of Escherichia coli enterotoxin results in a loss of its toxic activity. Journal of Biological Chemistry 1990, 265, 22520-22525.
25. 25 Okamoto, K., Okamoto, K., Miyama, A., Tsuji, T., Honda, T. and Miwatani, T. Effect of substitution of glycine for arginine at position 146 of the A1 subunit on biological activity of Escherichia coli heat-labile enterotoxin. Journal of Bacteriology 1988, 170, 2208-2211.
26. 26 Davenport, F.M., Hennessy, A.V., Brandon, F.M., Webster, R.G., Barrett, C.D. Jr. and Lease, G.O. Comparison of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinins. Journal of Laboratory and Clinical Medicine 1964, 63, 5-13.
27. 27 Kirii, Y., Danbara, H., Komase, K., Arita, H. and Yoshikawa, M. Detection of enterotoxigenic Escherichia coli by colony hybridization with diotinylated enterotoxin probes. Journal of Clinical Microbiology 1987, 25, 1962-1965.
28. 28 Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K. and Pease, L.R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989, 77, 51-59.
29. 29 Clements, J.D. and Finkelstein, R.A. Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures. Infection and immunity 1979, 24, 760-769.
30. 30 Nakamura, S., Morita, T., Iwanaga, S., Niwa, M. and Takashi, K. A sensitive substrate for the clotting enzyme in horseshoe crab hemocytes. Journal of Biochemistry 1977, 81, 1567-1569.
31. 31 Donta, S.T., Moon, H.W. and Whipp, S.C. Detection of heat-labile Escherichia coli enterotoxin with the use of adrenal cells in tissue culture. Science 1974, 183, 334-336.
32. 32 Grant, C.C.R., Messer, R.J. and Cieplak, W. Jr. Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin. Infection and Immunity 1994, 62, 4270-4278.
33. 33 Pizza, M., Domenighini, M., Hol, W., Giannelli, V., Fontana, M.R., Giuliani, M.M., Magagnoli, C., Peppoloni, S., Manetti, R. and Rappuoli, R. Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Molecular Microbiology 1994, 14, 51-60.
34. 34 Tsuji, T., Inoue, T., Miyama, A. and Noda, M. Glutamic acid-112 of the A subunit of heat-labile enterotoxin from enterotoxigenic Escherichia coli is important for ADP-ribosyltransferase activity. FEBS Letters 1991, 291, 319-321.
35. 35 Lycke, N., Tsuji, T. and Holmgren, J. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. European Journal of Immunology 1992, 22, 2277-2281.